| 2012 | TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases | Hsu, CH; Peng, KL; Kang, ML; Chen, YR; Chu, CS; Yang, YC; Tsai, CH; Jeng, YM; Chen, YT; Lin, FM; Huang, HD; Lu, YY; Teng, Yching; Lin, ST; Shen, L; Lin, RK; Lee, SB; Hsu, H M; Yu, JC; Hsiao, PW ; Juan, LJ | Cell Reports 2(3), 568-579 | | | |
| 2015 | Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study | Ko, TM ; Tsai, CY; Chen, SY; Chen, KS; Yu, KH; Chu, CS; Huang, CM; Wang, CR; Weng, CT; Yu, CL; Hsieh, SC; Tsai, JC; Lai, WT; Tsai, WC; Yin, GD; Ou, TT; Cheng, KH; Yen, JH; Liou, TL; Lin, TH; Chen, DY; Hsiao, PJ; Weng, MY; Chen, YM; Chen, CH; Liu, MF; Yen, HW; Lee, JJ; Kuo, MC; Wu, CC; Hung, SY; Luo, SF; Yang, YH; Chuang, HP; Chou, YC; Liao, HT; Wang, CW; Huang, CL; Chang, CS; Lee, MT ; Chen, P; Wong, CS; Chen, CH ; Wu, JY ; Chen, YT ; Shen, CY ; Taiwan Allopurinol-SCAR Consortium | BMJ-British Medical Journal 351, h4848 | | | |
